In the present study, an in vitro-in vivo extrapolation of dissolution integrated to a physiologically based pharmacokinetics modeling approach, considering a product-specific particle size distribution and a self-buffering effect of the drug, is introduced and appears to be a promising translational modeling strategy to support drug product development, manufacturing changes and setting clinically relevant specifications for immediate release formulations containing ibuprofen and other weak acids with similar properties.
Keywords: absorption; dissolution; in vitro-in vivo (IVIVC) correlation(s); mechanistic modeling; particle size; physiologically based pharmacokinetic (PBPK) modeling.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.